These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10192226)

  • 1. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorización Ambulatoria de la Presión Arterial (MAPA)-Area 5 Working Group.
    Martínez MA; García-Puig J; Martín JC; Guallar-Castillón P; Aguirre de Cárcer A; Torre A; Armada E; Nevado A; Madero RS
    Am J Hypertens; 1999 Mar; 12(3):251-9. PubMed ID: 10192226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study.
    Martínez MA; Moreno A; Aguirre de Cárcer A; Cabrera R; Rocha R; Torre A; Nevado A; Ramos T; Neri J; Antón G; Miranda I; Fernández P; Rodríguez E; Miquel A; Martínez JL; Rodríguez M; Eisman C; Puig JG;
    J Hypertens; 2001 Feb; 19(2):319-26. PubMed ID: 11212976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men.
    Björklund K; Lind L; Vessby B; Andrén B; Lithell H
    Circulation; 2002 Jul; 106(1):63-8. PubMed ID: 12093771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.
    Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB
    Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry.
    Høegholm A; Kristensen KS; Bang LE; Nielsen JW
    J Hum Hypertens; 1998 Jul; 12(7):433-9. PubMed ID: 9702928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The determination of arterial pressure by the physician or the nurse: its relation to ambulatory pressure and left ventricular mass. The MAPA-Madrid Group. Monitorización Ambulatoria de la Presión Arterial (Ambulatory Monitoring of Arterial Pressure)].
    Martínez MA; Aguirre A; Sánchez M; Nevado A; Laguna I; Torre A; Manuel E; Villar C; García-Puig J
    Med Clin (Barc); 1999 Dec; 113(20):770-4. PubMed ID: 10680140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of mild hypertension by ambulatory blood pressure monitoring.
    Weber MA; Neutel JM; Smith DH; Graettinger WF
    Circulation; 1994 Nov; 90(5):2291-8. PubMed ID: 7955186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Pressure Monitoring. Task force V: White-coat hypertension.
    Pickering TG; Coats A; Mallion JM; Mancia G; Verdecchia P
    Blood Press Monit; 1999 Dec; 4(6):333-41. PubMed ID: 10602537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and 'white coat' effect.
    Kristensen KS; Høegholm A; Bang LE; Gustavsen PH; Poulsen CB
    Blood Press Monit; 2001 Jun; 6(3):125-31. PubMed ID: 11518834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masked hypertension and target organ damage in treated hypertensive patients.
    Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
    Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension.
    Cuspidi C; Marabini M; Lonati L; Sampieri L; Comerio G; Pelizzoli S; Leonetti G; Zanchetti A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1707-11. PubMed ID: 8903637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population.
    Bombelli M; Sega R; Facchetti R; Corrao G; Polo Friz H; Vertemati AM; Sanvito R; Banfi E; Carugo S; Primitz L; Mancia G
    J Hypertens; 2005 Mar; 23(3):513-20. PubMed ID: 15716691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters.
    Konstantopoulou AS; Konstantopoulou PS; Papargyriou IK; Liatis ST; Stergiou GS; Papadogiannis DE
    J Hum Hypertens; 2010 Mar; 24(3):151-7. PubMed ID: 19571827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood pressure control in hospital units in Spain].
    de la Sierra A; Barrios V; González-Segura D
    Med Clin (Barc); 2013 Jul; 141(2):47-52. PubMed ID: 22766063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria.
    McNiece KL; Gupta-Malhotra M; Samuels J; Bell C; Garcia K; Poffenbarger T; Sorof JM; Portman RJ;
    Hypertension; 2007 Aug; 50(2):392-5. PubMed ID: 17592068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White coat hypertension and white coat effect. Similarities and differences.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
    Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study.
    Palatini P; Mormino P; Santonastaso M; Mos L; Dal Follo M; Zanata G; Pessina AC
    Hypertension; 1998 Jan; 31(1):57-63. PubMed ID: 9449391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care.
    Pierdomenico SD; Mezzetti A; Lapenna D; Guglielmi MD; Mancini M; Salvatore L; Antidormi T; Costantini F; Cuccurullo F
    Eur Heart J; 1995 May; 16(5):692-7. PubMed ID: 7588903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.